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Abstract
Background: A variety of species and experimental designs have been used to study genetic influences on
alcohol dependence, ethanol response, and related traits. Integration of these heterogeneous data can be used to
produce a ranked target gene list for additional investigation.
Results: In this study, we performed a unique multi-species evidence-based data integration using three
microarray experiments in mice or humans that generated an initial alcohol dependence (AD) related genes list,
human linkage and association results, and gene sets implicated in C. elegans and Drosophila. We then used
permutation and false discovery rate (FDR) analyses on the genome-wide association studies (GWAS) dataset from
the Collaborative Study on the Genetics of Alcoholism (COGA) to evaluate the ranking results and weighting
matrices. We found one weighting score matrix could increase FDR based q-values for a list of 47 genes with a
score greater than 2. Our follow up functional enrichment tests revealed these genes were primarily involved in
brain responses to ethanol and neural adaptations occurring with alcoholism.
Conclusions: These results, along with our experimental validation of specific genes in mice, C. elegans and
Drosophila, suggest that a cross-species evidence-based approach is useful to identify candidate genes contributing
to alcoholism.

Background
Research on the genetics and neurobiology of alcoholism
uses a variety of study designs and model organisms. A
wealth of data are available, including linkage studies in
human alcoholics, microarray studies of inbred mouse
strains’ brains and rat brains exposed to ethanol, and studies of loss or gain of function of genes in organisms
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such as C. elegans and Drosophila [1,2]. Although results
or information across experiments are often compared
by individual researchers in order to generate hypotheses,
interpret results, or prioritize targets for follow up investigations [3], these analyses are not always done comprehensively and rarely include a cross-species approach
[4-7]. While data integration itself can be challenging,
how best to utilize combined results is also unclear.
Although pooled results may yield valuable insights,
there are potential benefits of using more systematic
approaches to generate quantitative rankings that can
then, in turn, guide additional studies. In particular, these
rankings could be applied to choosing molecular targets
for knockdown studies in model organisms or genetic
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association studies in humans. For this and other
approaches, evaluation is often needed in order to determine whether the rankings are effective at the end of the
data integration process.
Challenges exist for each stage of an integration process, including the creation of an empirical gene list
across species and platforms, scoring the information,
and then evaluating the scoring system itself. For example, once various data are collected, identifying the best
way to integrate them poses a problem since the criteria
for selecting gene lists often differ substantially across
studies. Specifically in microarray studies, the expression
of gene-specific transcripts is selected via statistical
threshold(s), but individual genes can have multiple
transcripts that may differ in their abundance [8].
Therefore, a given gene can yield multiple expression
values through microarray or next generation RNA
sequencing (RNA-Seq) analyses. Likewise, human
genetic association studies test multiple genetic markers,
usually single nucleotide polymorphisms (SNPs), across
a gene. In contrast, the results of genetic linkage or
quantitative trait locus (QTL) studies in humans or
mice can span tens of megabases and contain potentially
hundreds of genes. Furthermore, low replication rates
and identification of non-functional markers in most
studies makes the search for true genetic signals difficult
[9-11]. While there are issues with data reduction or
summarization, integration at the level of the gene can
be used as a link across a number of commonly used
approaches.
If genetic information is summarized at the gene level,
then each gene in the genome can be assigned a score for
each experiment or data set available. This measurement
can be quantitative or qualitative. For example, p-values
may be assigned to a gene within a quantitative trait
locus (QTL) or a linkage region. However, differences in
gene-specific p-values within an interval of interest may
be misleading since linkage peaks can shift, and variants
responsible for the linkage may not be at the peak itself.
In contrast, large numbers of genes may show altered
expression in microarray studies and represent real
changes due to signal cascades affecting entire gene networks. These correlated expression networks, in which a
large number of changes are expected, contrast with linkage regions, in which most if not all genes do not actually
contain variant(s) linked to the disease. A combined pvalue method can be used for quantitative analyses, but
this approach may present its own challenges. The individual data sources may not be weighted equally since the
relative magnitudes of the p-values can be vastly different
across platforms (e.g., mouse and human QTL studies).
To avoid such issues, qualitative scores that measure the
presence or absence of evidence above a threshold may
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be used, but thresholds have their own problems. Regardless of scoring choice, and despite some problems associated with each, a combined gene rank score can be
generated from data integration. These gene rank scores
can be used to perform weighted analysis or to define
gene subsets for further investigation.
The effectiveness of such ranking can be verified by
conducting further testing on genes ranked highly in the
analyses. Alternatively, because the design of genomewide association studies (GWAS) is hypothesis free, this
approach offers opportunities to empirically test a ranking method and provide insight into further refinement,
and all or most potential candidate genes can be tested
in one experiment. If higher ranked genes contain more
significant SNPs than a random set of genes, then the
utility of a cross-species and platform integration and
ranking approach would be demonstrated [12]. In this
report, we attempt to implement and evaluate the utility
of the approach outlined above by collecting data across
species and approaches, summarizing at the gene level,
ranking the genes, and testing the rankings in complex
traits related to alcoholism and ethanol response. We
included data generated from ethanol response experiments because this trait is one of the contributing factors for alcoholism [13].

Results
Ranked gene list

An initial list of 2458 genes that show altered expression
in mouse brain in response to ethanol in two previous
studies [3,14] was used as a starting point. These datasets
were abbreviated as MuAc and MuPref (see Figure 1).
Five additional data sources were used to construct a
score for these genes, including 1) genes showing altered
expression in the prefrontal cortex of human alcoholics
(abbreviated as HuAlc) [15], 2) linkage intervals from
published studies of the Collaborative Study on the
Genetics of Alcoholism (COGA) and the Irish Study of
Alcoholism samples (abbreviated as HuLink) [16-18], 3)
genes contained on a human addiction/alcoholism array
(abbreviated as HuAddChip) [19], 4) those from a smaller
list of ethanol-related genes compiled from Drosophila
(abbreviated as Dr) [20,21], and 5) a short list of ethanolrelated genes compiled from C. elegans (abbreviated as
Ce) [22]. Additionally, genes having cross-species hits
acquired bonus scores (the “Cross” score in our algorithm, see Table 1), as cross-species evidence was
regarded as an important factor in gene salience. Here,
we used score to estimate the evidence of a gene, rather
than using a quantitative measurement (e.g., significance
level, see section Materials and methods). We proposed
10 weighting score matrices (Table 1). The corresponding ranking results are shown in Table 2.
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Figure 1 Data sources and ranking score results using weighting score matrix 3. The details of weighting score matrix 3 are provided in
Table 1.

Alcohol dependence GWAS analysis for ranked genes

To assess the performance of our ranking algorithm and
weighting score matrices, we explored whether the
ranked genes showed non-random enrichment of

significant signals in alcoholism GWAS results. Specifically, we examined enriched association signals of
ranked genes in the COGA GWAS [23], one of the largest alcohol dependence GWAS datasets. To increase

Table 1 Ten weighting score matrices used in cross-species data integration and gene ranking.
Weighting score matrix (WSM)

Description

WSM1: (0.5,0.5,1,1,0.5,0.5,0.5,1) *

HuAlc, HuAddChip, and Cross ** given 1, all others 0.5

WSM2: (0.5,0.5,1,1,0.5,0.5,0.5,0.5)

HuAlc and HuAddChip given 1, all others 0.5

WSM3: (0.5,0.5,0.5,1,0.5,0.5,0.5,0.5)

HuAddChip given 1, all others 0.5

WSM4: (0.5,0.5,1,1,1,0.5,0.5,0.5)

All human data given 1, all others 0.5

WSM5: (1,1,1,1,0.5,0.5,0.5,0.5)

All mouse data, human HuAlc and HuAddChip given 1, all others 0.5

WSM6: (1,1,0.5,0.5,0.5,0.5,0.5,0.5)

All mouse data given 1, all others 0.5

WSM7: (1,1,1,1,1,0.5,0.5,0.5)

All mouse and human data given 1, all others 0.5

WSM8: (0.5,0.5,0.5,1,0.5,0.5,0.5,1)
WSM9: (1,1,1,1,1,1,1,1)

HuAddChip and Cross given 1, all others 0.5
All given 1

WSM10: (1,1,1,1,1,1,1,0.5)

All but Cross given 1

* The weights in the parentheses are in the order for the datasets: MuAc, MuPref, HuAlc, HuAddChip, HuLink, Ce, Dr, Cross, respective. The description of these
datasets is provided in Figure 1.
** Cross denotes the bonus score for genes who had cross-species hits except for genes from human linkage regions (see section Materials and methods).
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Table 2 Summary of the genes by their scores using 10
weighting matrices*.

Table 3 Empirical p-values estimated from 1000
permutations based on weighting score matrix 3.

Weighting
matrix

qvalue

Score
0.5

1

1.5

2

2.5

3

1

1722

535

40

38

102

21

2

1722

535

78

102

21

3
4

1966
1722

314
338

131
235

41
137

6
16

10

1966

220

137

112

15

1745

202

5
6

244

7
8

1966
1966

314

17

222

34

11

357

89

29

114

41

6

9

1966

314

10

1966

314

3.5

8
17

149
132

17

4

29
29

* For each matrix, scores of each gene were summarized based on its
evidence in each dataset (see details in Table 1). Then, the number of genes
in each score range was counted and summarized in this table.

the effect of our analyses we filtered the data for minor
allele frequency, Hardy-Weinberg equilibrium deviation,
and failure rate (see section Materials and methods).
This resulted in 958,380 SNPs in our follow up analysis,
with an observed minimum p-value of 9.5 × 10-7. However, the minimum q-value was 0.605 after False Discovery Rate (FDR) analysis. Of those SNPs approximately
68.7% (658,008/958,380) mapped to the human nonpseudogenes in NCBI Entrez Gene database, and they
were used in this study. FDR analysis was then performed on restricted subsets of markers based on gene
rank score.
For each ranked gene under different weighting score
matrices, we calculated the q-value of each SNP in the
gene from the COGA GWAS data. The results for the
ten weighting score matrices were summarized in Additional file 1. For each weighting score matrix, its gene
ranking performance was expected to increase by
improving the q-values of SNPs mapped in the ranked
genes. To quantitatively measure performance and correct for gene size, we conducted 100 simulations, in
each of which the same number of genes were randomly
chosen from the whole gene set. FDR based q-value
analysis was then performed on the GWAS genotyped
SNPs that mapped to the randomly chosen genes. The
proportion of q-values in each q-value bin (e.g., 0.1-0.2)
was calculated and then compared with those from the
actual ranked alcohol genes. For the simplicity of comparison, we separated q-values into different bins. The
results are shown in Additional file 1.
According to our permutation results, the weighting
score matrix 3 had the best performance, since it gave
the lowest q-values among genes (Additional file 1).
This matrix was then used to refine gene scores using
1000 permutations (Table 3). In general, the subset of

Gene score
≥1

≥1.5

≥2

= 2.5

q < 0.9 0.393
(6399)

≥0.5

0.367
(1863)

0.603
(399)

0.191
(866)

0.052
(178)

q < 0.8 0.525 (469)

0.292 (415)

0.441
(163)

0.310
(199)

0.131
(108)

q < 0.7 0.495 (8)

0.228 (164)

0.627 (5)

0.208
(117)

0.118 (72)

q < 0.6 0.286 (5)

N/A

N/A

0.225 (42)

0.093 (53)

q < 0.5 0.113 (5)

N/A

N/A

0.122 (39)

N/A

q < 0.4 0.012 (5)

N/A

N/A

0.101 (27)

N/A

Based on Table 2, we used weight matrix 3 to rank genes (a total of 2458
genes) and then separated them according to their q-values. The number of
SNPs in each q-value and score category based on COGA dataset is shown in
parentheses. N/A: not available due to absence of the real data at those
categories.

SNP results restricted to the scored genes was enriched
for significant effects as the gene rank score increased
from 0.5 to 2.0 (see Table 4). Specifically, the minimum
FDR based q-value was 0.605 for all SNPs passing QC.
The minimum q-value decreased for SNPs in all scored
genes, but then increased for genes with score ≥ 1 or ≥
1.5. However, the minimum q-value became the smallest
(0.357) when this analysis was applied to genes with
score ≥ 2. There were 47 genes whose scores were ≥ 2,
and a total of 2293 SNPs mapped to these genes. For
this gene subset, we found many more SNPs having
small q values, including 27 SNPs with q-value < 0.4
and 39 SNPs with q-value < 0.5, than those in other
gene sets (e.g., gene subset with score ≥ 1.5 or any
scored, Table 4). Although this q-value analysis was not
perfect (e.g., we did not find a steady decrease of qvalue by increasing gene score, Table 4), it suggests that
multi-species gene ranking by optimal weighting matrix
might be effective for prioritizing candidate genes for
complex traits.
Bioinformatics analysis of top ranked genes

As presented above and detailed in Table 5, 47 genes
with score ≥ 2 had promising q-value improvement, and
were used as our high priority list for follow up bioinformatics analysis. These genes also had evidence from
at least 2 different species (Figure 1). We first performed
functional enrichment analysis of Gene Ontology (GO)
terms implemented in the WebGestalt tool. In this tool,
each gene set is tested its functional enrichment with
GO annotations based on the hypergeometric test. As
shown in Table 6 the most significantly enriched functional terms belonged to the groupings of neurotransmitter receptor activity, ion binding, and synaptic
structure. The most significantly enriched functional
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Table 4 Improvement in GWAS-based association FDR as multi-species gene ranking score increases.
FDR
q-value

Total SNPs passing QC

Scored

Score ≥1

Score ≥1.5

Score ≥2

Score = 2.5

All SNPs

547920

91774

18988

7948

2293

210

< 0.9
< 0.8

48016
643

6399
469

1863
415

399
163

866
199

178
108

< 0.7

6

8

164

5

117

72

< 0.6

0

5

0

0

42

53

< 0.5

0

5

0

0

39

0

< 0.4

0

5

0

0

27

0

< 0.3

0

0

0

0

0

0

< 0.2

0

0

0

0

0

0

< 0.1
< 0.05

0
0

0
0

0
0

0
0

0
0

0
0

Min q

0.605

0.369

0.667

0.636

0.357

0.526

terms were behavior (pBH = 5.08 × 10-5), gamma-aminobutyric acid (GABA) signaling pathway (pBH = 8.51 ×
10-5) and cell communication (pBH = 0.0001) in the GO
category of “Biological Process"; GABA receptor activity
(pBH = 3.35 × 10-9), GABA-A receptor activity (pBH =
7.38 × 10-8), and neurotransmitter binding (pBH = 7.38
× 10 -8 ) in the category of “Molecular Function"; and
postsynaptic membrane (p BH = 1.86 × 10 -7 ), chloride
channel complex (pBH = 2.76 × 10-7), and synapse part
(pBH = 3.36 × 10-7) in the category of “Cellular Component”. Many of these enriched functional categories are
consistent with the current knowledge of alcohol dependence and ethanol response [24]. These indicate that the
top ranked genes are highly enriched in functions relevant to alcoholism.
To further investigate whether our approach to selecting the 47 genes is efficient, we compared the results
with a similar analysis of top-ranked genes based on p
values in COGA GWAS. We assigned the smallest p
value of the marker mapped to a gene to represent
gene-wise association significance. Then, we selected the
most significant 47 genes. No functional term was significant in GO term analysis. Of note, our results were
not corrected for gene length bias, a potential problem
in gene-based association studies [25]. This comparison
suggested that our cross-species gene ranking method
may be more useful in extracting biological meaning
from gene lists.
We further examined the function of the 47 genes
selected by cross-species ranking by using the ToppFun
online tool [26]. ToppFun provides enrichment analysis
of candidate genes in many biological categories, including GO terms, biological pathways, human and mouse
phenotypes, protein domains, and reference search in
PubMed. We presented the results of ToppFun as complementary information for WebGestalt analysis and
summarized the results of enriched pathways in Table 7

enriched mouse phenotypes in Table 8 and enriched
PubMed citations in Table 9. In the pathway analysis,
ToppFun uses a comprehensive collection of pathways
from major databases such as KEGG, Reactome, and
BioCarta [26]. The most enriched pathway is neuroactive ligand-receptor interaction (p = 5.36 × 10-5). Other
significant pathways included GPCR ligand binding and
G alpha signaling events; here, GPCR denotes G protein-coupled receptor (Table 7). Moreover, mouse phenotype analysis revealed that our selected genes are
involved in neuron-related activity (Table 8). Overall,
pathway and mouse phenotype enrichment analyses
confirmed the results obtained from the GO term
enrichment analysis by WebGestalt, and these analyses
also revealed highlighted genes related to synaptic activity and GABA signaling as being particularly represented
in significant pathways and mouse phenotypes. Finally,
we queried PubMed references by ToppFun to search
for publications that are overrepresented with genes
from our top ranked list (Table 9). The highest scored
record from this analysis was from a genetic study of
gene expression associated with alcohol consumption in
rats and humans [4], in which 24 of our top genes were
represented in the total of 130 genes described by this
study and showed significant enrichment (p < 1 × 10-6).
The second highest scored record was from an association study of 182 candidate genes in anorexia nervosa
(enrichment p < 1 × 10-6).

Discussion
In this work, we applied a unique cross-species, evidence-based gene prioritization strategy for genes
involved in alcoholism. We started with a set of genes
with prior microarray expression evidence of involvement in ethanol response, representing approximately
10% of the human protein-coding genes. These genes
were ranked using additional sources of evidence across
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Table 5 47 genes with ranked score ≥ 2 using weighting
score matrix 3.
Gene symbol

Gene ID

Score

TAC1

6863

2.5

JUN

3725

2.5

GABRB1
GABRA2

2560
2555

2.5
2.5

CCKBR

887

2.5

CCK

885

2.5

55858

2

TIMP2

7077

2

TH

7054

2

SPP1

6696

2

SLC6A11
PURB

6538
5814

2
2

TMEM165

PRKCE

5581

2

84152

2

5179

2

PDZRN3

23024

2

PDAP1

11333

2

5091

2

PBX1
NTSR2

5087
23620

2
2

NTRK2

4915

2

NR4A3

8013

2

NPY

4852

2

NPY2R

4887

2

MPDZ

8777

2

MAPK14

1432

2

MAN1A2
LAMB1

10905
3912

2
2

GSK3B

2932

2

GPRC5B

51704

2

GNG12

55970

2

GBA

2629

2

GABRG2

2566

2

GABRD

2563

2

GABRB2
GABBR1

2561
2550

2
2

FOXN3

1112

2

FOSL2

2355

2

EIF4EBP2

1979

2

DDX5

1655

2

CLIC4

25932

2

CHRM1

1128

2

CAPZB
BDNF

832
627

2
2

10396

2

440

2

63874

2

PPP1R1B
PENK

PC

ATP8A1
ASNS
ABHD4

multiple species, including humans, mice, C. elegans and
Drosophila. We used the COGA GWAS dataset and
applied permutation analysis to evaluate the best weighting score matrix for gene ranking. Based on these
results, we selected the top 47 genes with the best evidence for follow up bioinformatics analysis. Our functional enrichment test of these 47 genes suggested that
this ranking algorithm identifies gene sets with coherent
biological functions relevant to brain responses to ethanol and neural adaptations occurring with alcoholism.
Remarkably, higher ranking scores were predictive of
genes containing an enrichment of significant SNP associations in the context of COGA alcohol dependence
GWAS results. These results provide initial evidence
that a cross-species analysis of gene networks correlated
with molecular or behavioral responses to ethanol may
provide a powerful strategy to identify candidate genes
that contribute to alcoholism.
The identification of genes mediating biological
responses to ethanol, including the modification of risk
profiles for alcoholism, is an area of intense research
interest due to the possibility of pinpointing targets for
future alcoholism therapies. Recent advances in behavioral genetics and genomics have identified large numbers of genes that potentially contribute to phenotypic
responses to ethanol in both human and animal models.
However, little progress has been made in narrowing or
organizing these large lists of genes into a tractable
scheme for understanding the neurobiology and genetics
of alcoholism. One approach that has been used for
large collections of microarray data has been the performance of a meta-analysis across data on rodent models
of divergent ethanol drinking collected from multiple
centers and strains [3]. However, this analysis identified
3,800 genes associated with variation in ethanol intake,
making downstream hypothesis-driven studies difficult
to formulate.
As discussed in the Background, in our research
approach, we pursued a gene ranking algorithm constructed to integrate data on ethanol-related genes
across species. We recognized that direct behavioral parallels with ethanol response across humans, mice, Drosophila and C. elegans were likely to be tenuous or nonexistent. However, molecular commonalities underlying
ethanol responses across species, if they could be identified, should provide a powerful validation mechanism
for candidate genes involved in ethanol behavioral
responses, even if those particular behavioral components differ across species.
Our ranking algorithm, while largely empirical at this
stage, identified a ranked list of genes with obvious
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Table 6 Functional enrichment test for the 47 top ranked genes using WebGestalt.
GO ID*

Term

# genes

p-value

GO:0007610 (BP)

Behavior

11

1.17 × 10-7

5.08 × 10-5

-7

8.51 × 10-5

-7

GO:0007214 (BP)

Gamma-aminobutyric acid signaling pathway

4

pBH**

3.92 × 10

GO:0007154 (BP)

Cell communication

29

7.66 × 10

0.0001

GO:0007631 (BP)

Feeding behavior

5

2.16 × 10-6

0.0002

GO:0050794 (BP)

Regulation of cellular process

37

3.00 × 10-6

0.0002

GO:0050789 (BP)

Regulation of biological process

38

1.73 × 10-6

0.0002

GO:0033555 (BP)

Multicellular organismal response to stress

4

3.21 × 10-6

0.0002

GO:0007186 (BP)
GO:0007166 (BP)

G-protein coupled receptor protein signaling pathway
Cell surface receptor linked signal transduction

14
19

4.88 × 10-6
2.53 × 10-6

0.0002
0.0002

GO:0065007 (BP)

Biological regulation

38

8.70 × 10-6

0.0003

GO:0016917 (MF)

GABA receptor activity

6

3.22 × 10-11

3.35 × 10-9

GO:0004890 (MF)
GO:0042165 (MF)
GO:0030594 (MF)
GO:0005254 (MF)

GABA-A receptor activity

5

Neurotransmitter binding

7.38 × 10-8

-8

9.26 × 10-7

-8

1.26 × 10-6

-8

2.13 × 10

6

Chloride channel activity

7.38 × 10-8

-9

1.93 × 10

7

Neurotransmitter receptor activity

-9

3.56 × 10

6

6.04 × 10

GO:0005253 (MF)
GO:0031404 (MF)

Anion channel activity
Chloride ion binding

6
6

9.06 × 10
9.06 × 10-8

1.35 × 10-6
1.35 × 10-6

GO:0043168 (MF)

Anion binding

6

2.64 × 10-7

3.43 × 10-6

5

-6

2.57 × 10-5

-6

4.15 × 10-5

-9

1.86 × 10-7

-9

2.76 × 10-7

-8

3.36 × 10-7

-7

GO:0005230 (MF)
GO:0008509 (MF)
GO:0045211 (CC)
GO:0034707 (CC)
GO:0044456 (CC)

Extracellular ligand-gated ion channel activity
Anion transmembrane transporter activity

2.22 × 10

6

Postsynaptic membrane

3.99 × 10

8

Chloride channel complex

2.22 × 10

6

Synapse part

6.57 × 10

9

1.20 × 10

GO:0045202 (CC)
GO:0030054 (CC)

Synapse
Cell junction

9
9

2.51 × 10
5.88 × 10-6

5.27 × 10-6
9.88 × 10-5

GO:0034702 (CC)

Ion channel complex

6

1.53 × 10-5

0.0002

GO:0044459 (CC)

Plasma membrane part

16

1.70 × 10-5

0.0002

GO:0031226 (CC)

Intrinsic to plasma membrane

11

0.0002

0.0019

GO:0005887 (CC)

Integral to plasma membrane

11

0.0002

0.0019

GO:0033267 (CC)

Axon part

3

0.0003

0.0025

* BP: biological process; MF: molecular function; and CC: cellular component.
** BH: p-value corrected by the Benjamini-Hochberg method (1995) [50].

coherence in terms of functional gene networks. A
remarkably large number of genes already validated as
altering behavioral responses to ethanol were contained
in the higher ranks. In addition, bioinformatics analysis

showed several interesting biological functions that were
over-represented among the ranked genes (Tables 6, 7,
8, 9), which is largely consistent with our previous analysis based on a network approach [27]. Again, a

Table 7 Pathways significantly associated with top candidate genes by ToppFun.
Pathway ID/name

Description

Source

p-value

hsa04080

Neuroactive ligand-receptor
interaction
Genes involved in GPCR ligand
binding
Genes involved in Peptide ligandbinding receptors

KEGG pathway

5.36 × 10-5 10

256

MSigDB: C2.cp - 2.66 × 10-3 10
Reactome
MSigDB: C2.cp - 4.36 × 10-3 7
Reactome

392

REACTOME_DOWNSTREAM_EVENTS_IN_GPCR_SIGNALING Genes involved in Downstream
events in GPCR signaling

MSigDB: C2.cp - 8.63 × 10-3 10
Reactome

448

REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS

Genes involved in Class A/1
(Rhodopsin-like receptors)

MSigDB: C2.cp - 1.62 × 10-2 8
Reactome

292

REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS

Genes involved in G alpha (q)
signaling events

MSigDB: C2.cp - 2.78 × 10-2 6
Reactome

157

REACTOME_GPCR_LIGAND_BINDING
REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS

Terms in Terms in
query
genome

173
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Table 8 Mouse phenotypes significantly associated with top candidate genes by ToppFun.
Phenotype ID

Phenotype name

p-value

Terms in query

Terms in genome

MP:0009745

Abnormal behavioral response to xenobiotic

6.77 × 10-7

12

215

MP:0002206

Abnormal CNS synaptic transmission

4.31 × 10-6

14

382

MP:0003635

Abnormal synaptic transmission

3.57 × 10-5

14

450

MP:0002062

Abnormal conditioning behavior

6.87 × 10-5

10

199

MP:0002063

Abnormal learning/memory/conditioning

9.26 × 10-5

13

405

MP:0002065

Abnormal fear/anxiety-related behavior

1.05 × 10-4

10

208

MP:0001362

Abnormal anxiety-related response

3.59 × 10-4

9

179

MP:0002572
MP:0001454

Abnormal emotion/affect behavior
Abnormal cued conditioning behavior

8.34 × 10-4
1.41 × 10-3

11
6

329
66

MP:0003633

Abnormal nervous system physiology

2.44 × 10-3

20

1333

MP:0001399

Hyperactivity

2.57 × 10-3

9

226

MP:0001363

Increased anxiety-related response

2.86 × 10-3

7

117

MP:0009357

Abnormal seizure response to inducing agent

9.04 × 10-3

7

139

MP:0001449

Abnormal learning/memory

1.22 × 10-2

10

349

MP:0003088

Abnormal prepulse inhibition

1.45 × 10-2

5

57

MP:0003313
MP:0000950

Abnormal locomotor activation
abnormal seizure response to pharmacological agent

1.46 × 10-2
1.53 × 10-2

13
6

630
99

MP:0002945

Abnormal inhibitory postsynaptic currents

1.58 × 10-2

5

58

MP:0004008

Abnormal GABA-mediated receptor currents

2.85 × 10-2

3

11

MP:0009747

Impaired behavioral response to xenobiotic

3.45 × 10-2

5

68

MP:0004747

Abnormal cochlear OHC afferent innervation pattern

3.48 × 10-2

2

2

number of individual gene members from the constructed networks have strong prior validation as candidate genes that influence alcoholism traits in humans or
behavioral responses to ethanol in animal models. These
validated genes serve to increase the probability for the
entire gene network playing a role in ethanol responses.
Although gene targeting approaches in animal models
might ultimately be the most robust method for validating the role of individual genes in ethanol response behaviors, such studies are complex and time-consuming. We
chose, as an initial approach to validate our cross-species
ranking algorithm, a study of the association of the gene
ranking score with alcoholism traits in a GWAS analysis.
We found a reduction in the minimum FDR q-value as
the ranking score increased to 2. It is important to note
that this effect is not due to the progressive limiting of
markers examined. In this study, FDR is not dependent
on the number of tests performed.

Although the results are encouraging, the limitations of
the current analysis and possible improvements must be
noted. We noted that when the gene rank score cutoff
increased from 2.0 to 2.5, the size of the q-values
reversed. This observation might be attributed to overly
restricted gene selection given that number of SNPs in
genes dropped from 2293 in 47 genes to 210 in only 6
genes. Another limitation is that the use of genes from
the addiction/alcoholism array represents hypotheses
about important genes, as selected by expert review,
rather than selection from empirical association data. We
could improve the current approach in the following
ways. First, although we included seven datasets in the
gene ranking, many additional datasets now exist or will
be released in the near future that may be used in multispecies data integration. Additionally, this single GWAS
dataset is likely to be underpowered given the recent evidence showing many loci of small effect influence most

Table 9 PubMed citations significantly over-represented with top candidate genes by ToppFun.
PubMed
ID

Description

p-value

Terms in
query

Terms in
publication

19874574 Genetical genomic determinants of alcohol consumption in rats and humans.

< 1 × 10-6

24

130

20468064 Association study of 182 candidate genes in anorexia nervosa.

< 1 × 10-6

15

182

18985723 GABA neurotransmitter signaling in the developing mouse lens: dynamic regulation of
components and functionality.

< 1 × 10-6

7

18

21205893 TrkB receptor controls striatal formation by regulating the number of newborn striatal
neurons.

< 1 × 10-6

6

12

16987237 Reduced expression of neuropeptide genes in a genome-wide screen of a
secretion-deficient mouse.

< 1 × 10-6

8

67
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complex human traits. However, a network or pathway
analysis approach to analyze a set of genes might improve
power [12].
While there are undoubtedly numerous ways to score
or weight genes, we have shown that this simple empirical approach is effective. Our results demonstrate the
utility of gene ranking after cross-species data integration. Since this initial study demonstrated the utility of
this approach, we are continuing to expand the number
of data sets and improve the scoring scheme through a
more sophisticated optimization of weighting parameters. As more data is included, additional alcohol
GWAS results become available, and more sophisticated
gene ranking algorithms are developed, we expect
improvement in specificity and sensitivity. For example,
there are many gene expression studies in rat brain
from animals evaluated for alcohol-preference behavior
[2,28-31], and they will be integrated in future gene
ranking. However, our initial gene targeting experiments
in animal models, using the ranked gene lists derived in
this study, have already identified several novel genes
that alter ethanol response behaviors in mice, Drosophila or C. elegans (unpublished data). This provides
direct support of our cross-species gene ranking.

Conclusion
In this study, we proposed a cross-species, evidencebased gene ranking strategy and demonstrated it in the
eight alcoholism or ethanol response related datasets
from four species (human, mouse, fly, and worm).
Through the use of permutation and FDR analyses, we
evaluated 10 weighting score matrices and found that
one of them had the best performance. Using this optimal weighting matrix, we selected 47 genes whose
scores were greater than 2 for follow up bioinformatics
analysis. Functional enrichment tests revealed that these
47 genes are involved in brain responses to ethanol and
neural adaptations occurring with alcoholism. Our
results, with further experimental validation in three
animal models, suggest that our approach is useful for
cross-species gene prioritization.
Materials and methods
Cross species gene ranking

In an effort to populate an inclusive gene list with nonbiased data from at least two species, we used published
microarray gene expression data from our own and
other laboratories. As shown in Figure 1, microarray
gene expression data was used from three sources: acute
responses to ethanol in C57BL/6 and DBA2/J mice
(whole genome analysis of samples from reference [14])
that had been supplemented with additional microarray
studies (U74B and U74C arrays, Affymetrix) on the
same samples, a meta-analysis of genes involved in
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ethanol preference drinking across multiple mouse
strains [3], and analysis of prefrontal cortex from autopsied samples of alcoholic and non-alcoholic brains [15].
We then merged these datasets by utilizing gene homology mapping features within the WebGestalt [32]. This
produced a list of 2458 genes. These genes were ranked
by scores resulting from the following algorithm:
S = w1 (MuAc) + w2 (MuPref) + w3 (HuAlc) + w4 (HuAddChip)
+w5 (HuLink) + w6 (Ce) + w7 (Dr) + w8 (Cross).

The symbols refer to sources diagramed in Figure 1.
MuAc, MuPref and HuAlc refer to presence in the
microarray studies mentioned above. HuAddChip are
selected genes from human association studies on alcohol
dependence using the “addiction chip” designed by David
Goldman and colleagues at the National Institute on
Alcohol Abuse and Alcoholism (NIAAA) [19]. HuLink
refers to genes contained within linkage regions that have
been implicated multiple times across human studies of
alcohol-related phenotypes on chromosomes 1, 4, and 7
[16-18]. The region on chromosome 1 ranges from
D1S1613 at 64,007,000 bp to D1S2624 at 154,898,000 bp
(according to HapMap build 36) and encompasses a variety of overlapping linkage signals to alcohol-related phenotypes, including alcohol dependence, heavy drinking,
sensitivity to alcohol, and tolerance, across a number of
samples [17,18,33-38]. The chromosome 4 region ranges
from D4S2382 at 39,727,200 bp to D4S1615 at
128,429,200 bp and encompasses linkage peaks from four
independent samples [16,18,39-42]. The chromosome 7
region ranged from D7S691 at 41,996,200 bp to D7S1817
at 109,026,000 bp and constitutes the strongest linkage
region in the Collaborative Study of the Genetics of Alcoholism (COGA) sample [18,43-45]. The invertebrate gene
sets are from published studies in C. elegans [22] and
Drosophila [20,21]. Finally, the “Cross” term is a bonus
score added for cross-species hits for a given gene except
for genes from human linkage regions. The weighting
terms wi (i = 1, 2, 3, ... 8) were empirically chosen with
0.5 or 1.0 in 10 different weighting score matrices (Table
1). After a permutation test with COGA GWAS data, we
found the weighting score matrix 3 could provide the
best performance.
Analysis of COGA alcohol dependence GWAS dataset

The COGA GWAS dataset was used to evaluate the
gene rankings. It contains 1205 cases and 700 controls
[23]. All cases met DSM-IV criteria for alcohol dependence. Controls were defined as individuals who have
consumed alcohol, but did not meet any definition of
alcohol dependence or alcohol abuse, nor did they meet
any DSM-IIIR or DSM-IV definition of abuse or dependence for other drugs (except nicotine). The Illumina
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human 1M chipset was used for genotyping. Only DNA
samples achieving a call rate of > 95% were included. A
total of 1,041,465 SNP markers were used for case-control analyses. We conducted population stratification
and association analyses using PLINK, a highly flexible,
fast, and user-friendly package for GWAS analysis [46].
In our analyses we included only SNPs if their genomewide failure rate did not exceed 0.05. SNPs were further
excluded if minor allele frequency was less than 0.01.
After these data filtering processes, 958,380 SNPs were
used for further analyses. Then, we mapped these SNPs
to non-pseudogenes in the NCBI Entrez Gene database.
Specifically, a SNP belongs to a gene if it locates in the
region within 10 kb upstream to 10 kb downstream of
the gene.
FDR control

To control the risk of false discoveries in GWAS studies, for each p-value, we calculated a q-value [47,48]. A
q-value is an estimate of the proportion of false discoveries among all significant markers (i.e., q-values are
FDRs) when the corresponding p-value is used as the
threshold to declare significance. As argued previously
[49], we preferred this approach to more traditional
multiple testing methods that control the probability of
producing one or more false discoveries for a set of
tests [50]. Our approach was preferred because these qvalues 1) provide a better balance between the competing goals of finding true positives versus controlling
false discoveries, 2) allow the use of more similar standards in terms of the proportion of false discoveries produced across studies due to much less dependence on
the number of tests performed, 3) are relatively robust
against the effects of correlated tests [47,49,51-56], and
4) rather than an all-or-nothing conclusion about
whether a study produces significant results, instead
provide a more subtle picture about the possible relevance of the tested markers. The FDR procedure is performed in the R statistical package.
Random permutation for different score matrix

To test the significance of the gene ranking enrichment
result for each weighting score matrix, we did 100 random permutations for the q-value enrichment. Since
longer genes tend to have more SNPs in GWAS data, to
reduce this gene length bias, we restricted the gene
length of the random selections in each permutation
within ± 50 kb of the average length of our ranked
genes. We set the permutation p-value as the proportion
of permutation times in which there are higher q-value
proportions in randomly selected genes than in our
ranked genes in the corresponding score region. For
example, there were n genes with a score s under a specific weighting score matrix. Then, in each permutation,
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n genes were selected from all human genes whose
length is ± 50 kb of the average length of the n ranked
genes. The q-values for SNPs in the randomly selected
genes were calculated based on the GWAS data. For
simplicity of comparison, we compared the number of
SNPs in each q-value range (e.g., < 0.9, < 0.8, etc.). The
proportion of the q-value number for each q-value
range in randomly selected genes was then calculated. If
the proportion was larger than our ranked alcohol genes
at the same q-value range, we counted this permutation
as a “significant permutation” for the specific score
range s and q-value range. After 100 permutations, the
proportion of “significant permutation” was set as the pvalue of our permutation result at the corresponding
score and q-value range. For the weighting score matrix
with the best performance, permutation testing was
repeated 1000 times again to check the significance.
Bioinformatics analysis of cross-species ranked gene list

The 47 top ranked genes with a score ≥ 2 were examined for enriched GO terms using the WebGestalt
online tool (version 2) [32]. This tool examines the
over-representation of genes of interest in GO terms
based on the hypergeometric test followed by the Benjamini-Hochberg (1995) adjustment of p-values [50]. We
then used the ToppFun online tool [57], which is an
integrated over-representation analysis tool, to interrogate databases for biological pathways, mouse phenotypes, and PubMed citations.

Additional material
Additional file 1: Summary of the number and proportion of qvalues, and p-value of 100 permutation results for different ranked
score and q-value range under each of the 10 weighting score
matrices.
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